• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Sterling lands Canadian PACS deal

Article

Sterling Diagnostic Imaging's efforts to compete in the PACS market are meeting with success. The Greenville, SC, vendor has landed its second large-scale Canadian PACS site, at Region 3 Hospital Corporation in New Brunswick, Canada. Although Region 3

Sterling Diagnostic Imaging's efforts to compete in the PACS market are meeting with success. The Greenville, SC, vendor has landed its second large-scale Canadian PACS site, at Region 3 Hospital Corporation in New Brunswick, Canada. Although Region 3 officials were reluctant to quantify the cost of the purchase, they did say that they have invested roughly $1 million (U.S.) in the technology, including the iiLinx printer network that serves as the foundation for the PACS network. Region 3 joins another Canadian Sterling PACS customer, Atlantic Health Sciences (AHSC) of Saint John, also in New Brunswick. AHSC signed a multimillion-dollar contract with Sterling in April (SCAN 4/16/97).

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.